Eli Lilly and Co News

Eli Lilly and Co | 8-K: Current report

Aug 14 12:30 ET

Eli Lilly and Co | 424B2: Prospectus

Aug 13 16:35 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Officer Hakim Anat

Aug 13 16:26 ET

Eli Lilly and Co | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 12 16:56 ET

Eli Lilly and Co | 424B2: Prospectus

Aug 12 08:15 ET

Eli Lilly and Co | 10-Q: Q2 2024 Earnings Report

Aug 8 11:34 ET

Eli Lilly and Co | 8-K: Current report

Aug 8 07:09 ET

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

Aug 5 17:07 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Officer Seymour Melissa

Aug 2 16:05 ET

Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)

Aug 1 06:12 ET

Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Seymour Melissa

Jul 30 16:19 ET

Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Brooks Gordon J.

Jul 19 16:21 ET

Eli Lilly and Co | SC TO-T: Third party tender offer statement

Jul 19 06:11 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

Jul 16 16:27 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

Jul 16 16:24 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R

Jul 16 16:23 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Hedley Mary Lynne

Jul 16 16:23 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph

Jul 16 16:23 ET

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC

Jul 11 16:01 ET

Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 10 13:20 ET